Afuco™ Anti-FAP ADCC Recombinant Antibody (Sibrotuzumab), ADCC Enhanced (CAT#: AFC-TAB-211)

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to FAP. Sibrotuzumab is a humanized monoclonal antibody intended for the treatment of cancer. It binds to FAP.

Specific Inquiry Online Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Normal Tissue
RNA Expression


  • Immunogen
  • A synthetic peptide derived from human Fibroblast activation protein, alpha.
  • Host Species
  • Human
  • Derivation
  • Humanized (from mouse)
  • Type
  • ADCC enhanced antibody
  • Species Reactivity
  • Human
  • Clone
  • Sibrotuzumab
  • Applications
  • ELISA, IP, FC, FuncS, Neut, IF
  • Conjugate
  • Unconjugated
  • Generic Name
  • Sibrotuzumab
  • Related Disease
  • Unknown

Product Property

  • Purity
  • >95% by SDS-PAGE
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.


  • Alternative Names
  • Sibrotuzumab; 216669-97-5; BIBH 1; humanized F19; FAP; fibroblast activation protein, alpha; seprase; DPPIV; integral membrane serine protease; 170 kDa melanoma membrane-bound gelatinase; FAPA; DKFZp686G13158;

Related Resources

  • Biosimilar Overview
Please refer to Sibrotuzumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Sibrotuzumab.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.


Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Sibrotuzumab"

Anti-Human FAP Recombinant Antibody (Sibrotuzumab)
Recombinant monoclonal antibody to FAP. Sibrotuzumab is a humanized monoclonal antibody intended for the treatment of cancer. It binds to FAP.

See other products for "Fap"

Select a product category from the dropdown menu below to view related products.
Please select product type
Humanized Antibody Human Antibody Fc Glycosylation Low- or Non-fucosylated Oligosaccharide Recombinant Antibody scFv Fragment Antibody Fab Fragment Antibody Single-domain Antibody MHC Tetramer for Cancer
CAT Product Name Application Type
TAB-211 Anti-Human FAP Recombinant Antibody (Sibrotuzumab) ELISA, IP, FC, FuncS, Neut, IF, WB IgG1 - kappa

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for AFC-TAB-211. Click the button above to contact us or submit your feedback about this product.

Popular products with customers

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • 0
  • 0
    Go to compare

    Go to compare